Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biophytis Sa ADR (NQ: BPTS ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Biophytis Sa ADR < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Biophytis is Deploying its Partnership Strategy in Obesity April 29, 2024 Via ACCESSWIRE Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 25, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday April 25, 2024 Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning! Via InvestorPlace Biophytis Announces New Scientific Advisory Board for its Phase 2 OBA Clinical Study in Obesity April 17, 2024 Via ACCESSWIRE Biophytis launches OBA phase 2 clinical study in obesity with BIO101 (20-hydroxyecdysone) April 08, 2024 Via ACCESSWIRE Why Teradyne Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket April 25, 2024 Via Benzinga Biophytis Announces Transfer of ADSs to OTC Market April 24, 2024 Via ACCESSWIRE Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 22, 2024 It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning! Via InvestorPlace Results of the Combined General Meeting on April 2, 2024 April 04, 2024 Via ACCESSWIRE Biophytis Announces Ratio Change Under its American Depositary Receipt (“ADR”) Program April 18, 2024 Via ACCESSWIRE Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket April 15, 2024 Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals. Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session April 10, 2024 Via Benzinga Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 10, 2024 Shares of Ascent Solar Technologies, Inc. (NASDAQ: ASTI) fell sharply during Wednesday’s session after the company announced pricing of a $6 million public offering of shares at $0.14 per share. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 10, 2024 Via Benzinga Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket April 10, 2024 Shares of PriceSmart, Inc. (NASDAQ: PSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 10, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday April 10, 2024 Pre-market stock movers are worth diving into on Wednesday morning to get ready for all of the hottest news moving shares today! Via InvestorPlace Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free Via Benzinga Dow Dips 150 Points; Laser Photonics Shares Spike Higher April 09, 2024 U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P... Via Benzinga Topics Stocks Exposures US Equities Why Is Penny Stock Biophytis Trading Higher On Tuesday? April 09, 2024 Announcing OBA clinical development program by Biophytis with BIO101 (20-hydroxyecdysone) for obesity treatment. Phase 2 study expected mid-2024, with efficacy results anticipated in 2025. Via Benzinga Why Is Vincerx Pharma (VINC) Stock Down 64% Today? April 09, 2024 Vincerx Pharma stock is falling hard on Tuesday after the company failed to impress VINC shareholders with its latest clinical trial update. Via InvestorPlace Why Is MyMD Pharmaceuticals (MYMD) Stock Up 35% Today? April 09, 2024 MyMD Pharmaceuticals stock is rising on Tuesday as MYMD investors react to new amendment to a securities purchase agreement. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 09, 2024 Via Benzinga Why Is Biophytis (BPTS) Stock Up 43% Today? April 09, 2024 Biophytis stock is up on Tuesday after the company provided BPTS shareholders with results for the fiscal full year of 2023! Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 09, 2024 Pre-market stock movers are worth checking out as we get into all of the hottest news investors need to know about on Tuesday morning! Via InvestorPlace Why Biophytis Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Moving Premarket April 09, 2024 Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results. Via Benzinga Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities April 08, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Friday's After-Market Session March 29, 2024 Via Benzinga Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket March 25, 2024 Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results. Via Benzinga Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session March 21, 2024 Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 11 12 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.